Cytokinetics, Incorporated and Families of Spinal Muscular Atrophy announced the award of a grant from FSMA to Cytokinetics to support preclinical research on muscle function in a mouse model of spinal muscular atrophy to be conducted with the company`s fast skeletal muscle troponin activator, tirasemtiv.
http://www.sbwire.com/press-releases/pre-market-trading-commentary-on-high-volume-stocks-nasdaq-cytk-nasdaq-arry-237708.htm
http://www.sbwire.com/press-releases/pre-market-trading-commentary-on-high-volume-stocks-nasdaq-cytk-nasdaq-arry-237708.htm
No comments:
Post a Comment